Fate Therapeutics (NQ: FATE )

76.70 USD +5.19 (+7.26%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2021 Add to My Watchlist

Price and Volume

Volume	1,710,030
Open	71.42
Bid (Size)	72.34 (1)
Ask (Size)	77.00 (15)
Prev. Close	71.51
Today's Range	71.40 - 79.00
52wk Range	26.15 - 121.16
Shares Outstanding	94,035,763
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Fate Therapeutics Announces Encouraging Interim Phase 1 Data for iPSC-derived NK Cell Programs in Relapsed / Refractory Acute Myeloid Leukemia

May 13, 2021

Fate Therapeutics Reports First Quarter 2021 Financial Results and Highlights Operational Progress

May 05, 2021

Performance

YTD	-14.47%	-14.47%
1 Month	-9.48%	-9.48%
3 Month	-25.13%	-25.13%
6 Month	+51.85%	+51.85%
1 Year	+188.13%	+188.13%

More News

Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2021 Financial Results

April 29, 2021

Fate Therapeutics Announces Four Presentations at the 2021 ASGCT Annual Meeting

April 27, 2021

Fate Therapeutics' iPSC-Derived Cell Therapies Induce Leukemic Blast Clearance, Show Durable Remissions In AML Patients

May 14, 2021

Fate Therapeutics Breaks Below 200-Day Moving Average - Notable for FATE

May 13, 2021

12 Health Care Stocks Moving In Thursday's After-Market Session

May 13, 2021

Preview: Fate Therapeutics's Earnings

May 04, 2021

Fate Therapeutics Moves Up In Market Cap Rank, Passing PVH

April 30, 2021

Fate Therapeutics Inc (FATE) Q1 2021 Earnings Call Transcript

May 06, 2021

Stocks Showing Market Leadership: Fate Therapeutics Earns 92 RS Rating

April 27, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.